- Home
- BHF vs AMRX Comparison
BHF vs AMRX Comparison
Compare BHF & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHF
- AMRX
- Stock Information
- Founded
- BHF 2016
- AMRX 2002
- Country
- BHF United States
- AMRX United States
- Employees
- BHF N/A
- AMRX N/A
- Industry
- BHF Life Insurance
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- BHF Finance
- AMRX Health Care
- Exchange
- BHF Nasdaq
- AMRX Nasdaq
- Market Cap
- BHF 2.8B
- AMRX 2.3B
- IPO Year
- BHF N/A
- AMRX N/A
- Fundamental
- Price
- BHF $59.81
- AMRX $7.32
- Analyst Decision
- BHF Hold
- AMRX Strong Buy
- Analyst Count
- BHF 10
- AMRX 4
- Target Price
- BHF $57.90
- AMRX $11.50
- AVG Volume (30 Days)
- BHF 846.7K
- AMRX 1.9M
- Earning Date
- BHF 05-08-2025
- AMRX 05-02-2025
- Dividend Yield
- BHF N/A
- AMRX N/A
- EPS Growth
- BHF N/A
- AMRX N/A
- EPS
- BHF 8.45
- AMRX N/A
- Revenue
- BHF $8,610,000,000.00
- AMRX $2,830,186,000.00
- Revenue This Year
- BHF $42.62
- AMRX $10.20
- Revenue Next Year
- BHF $2.05
- AMRX $7.15
- P/E Ratio
- BHF $7.08
- AMRX N/A
- Revenue Growth
- BHF 165.09
- AMRX 13.42
- 52 Week Low
- BHF $40.00
- AMRX $6.29
- 52 Week High
- BHF $64.12
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- BHF 55.86
- AMRX 46.61
- Support Level
- BHF $58.18
- AMRX $7.02
- Resistance Level
- BHF $60.94
- AMRX $7.39
- Average True Range (ATR)
- BHF 1.81
- AMRX 0.18
- MACD
- BHF -0.19
- AMRX -0.00
- Stochastic Oscillator
- BHF 48.37
- AMRX 45.80
About BHF Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.